This year marks the 2nd edition of the conference on Particles in Injectables in Berlin from 26-27 September and the 10th Anniversary of PDA Europe's Monoclonal Antibodies Workshop.
The Particles in Injectables conference provides you with a summary of information on the risks to human health associated with particulate matter. Particles can arise from many sources: foreign, intrinsic, or inherent to the product.
Particulate matter, visible or subvisible, in sterile parenteral products is regarded a critical quality attribute, impacting patient safety. A session will focus on the nature and sources of these particles in parenterals and in infusion sets used in clinical studies and hospitals. The difference between particles in drugs and clinical infusions will be highlighted.
Furthermore, packaging materials, such as glass vials, syringes and rubber stoppers, are known to be major sources of particulate contamination. A session will discuss defects in packaging materials and strategies employed to detect and control them. And last but not least, manual inspection continues to provide the critical reference method for all compendial inspection activity.
For any further information, please contact us at email@example.com.